Aurobindo Pharma receives Swissmedic approval for cefepime for injection
BS Reporter / Hyderabad Aug 27, 2009, 12:57 IST
Hyderabad-based Aurobindo Pharma Limited received approval from Swissmedic, an agency of Switzerland government for therapeutic products, for the licence of Cefepime APL for injection 1g and 2g.
This is used for moderate to severe pneumonia, septicaemia, skin and intra-abdominal infections. This is Auorbindo's second product approval from Swissmedic, according to a press release.